GeneDx Holdings (WGS)

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

The GeneDx Holdings Corp. Class A Common Stock (WGS) stock price today is $79.61, reflecting a -2.22% move since the market opened. The company’s market capitalization stands at $2.30B, with a daily trading volume of $804.18K shares. For investors tracking price trends, GeneDx Holdings Corp. Class A Common Stock stock has ranged between $76.61 and $79.75 today. The previous closing price was $81.42.

Ready to get started? Follow the steps below, or read our guide on how to buy GeneDx Holdings stock on Kraken starting from $10.